Loading
AG
Aevi Genomic Medicine, LLC Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by COLA MICHAEL F, was filed 11 Jun 2020.
Aevi Genomic Medicine, LLC: what insiders have been doing
Aevi Genomic Medicine, LLC is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Aevi Genomic Medicine, LLC has published a filing in the past twelve months. The most recent one dates from 11 June 2020.
Our records for Aevi Genomic Medicine, LLC go back to 2016, with 27 purchases and 1 sale on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
46
Thresholds
n/a
Buy Volume
€8M
27 ops. · all time
Sell Volume
€495,562
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Net income-27.4M
Last declaration on 11 June 2020
Declarations46 total
100,000 shares@ US$2.5047.1% of flowCommon StockSEC:0001192482-20-000475:0
Canonical exit: 7 Sept 2020 (T+90)
12,946,900 sharesCommon StockSEC:0001104659-20-012390:0
Canonical exit: 18 Mar 2020 (T+90)
75,683 sharesCommon StockSEC:0001192482-20-000119:0
27,000 sharesCommon StockSEC:0001192482-20-000119:1
56,780 sharesCommon StockSEC:0001192482-20-000119:2
15,384 sharesCommon StockSEC:0001192482-20-000119:3
165,715 sharesCommon StockSEC:0001192482-20-000117:0
2,164,150 sharesCommon StockSEC:0001192482-20-000109:0
38,856,891 sharesCommon StockSEC:0001192482-20-000113:0
57,280,927 sharesCommon StockSEC:0001192482-20-000113:1
2,267,859 sharesCommon StockSEC:0001192482-20-000111:0
57,536 sharesCommon StockSEC:0001192482-20-000115:0
16,107 sharesCommon StockSEC:0001192482-20-000125:0
59,524 sharesCommon StockSEC:0001192482-20-000123:0
153,846 shares0Common StockSEC:0001192482-19-000509:0
153,846 shares0Common StockSEC:0001192482-19-000509:1
365,854 shares0Common StockSEC:0001192482-19-000509:2
365,854 shares0Common StockSEC:0001192482-19-000509:3
2,551,020 shares0Common StockSEC:0001192482-19-000509:4
2,551,020 shares0Common StockSEC:0001192482-19-000509:5
2,049,376 shares@ US$0.13452.9% of flowCommon StockSEC:0001192482-19-000513:0
Canonical exit: 4 Mar 2020 (T+90)
2,049,376 shares@ US$0.134100.0% of flowCommon StockSEC:0001192482-19-000511:0
Canonical exit: 4 Mar 2020 (T+90)
4,098,752 shares@ US$0.13418.7% of flowCommon StockSEC:0001192482-19-000509:6
26,000 shares@ US$1.1623.7% of flowCommon StockSEC:0001192482-18-000474:0
Canonical exit: 5 Feb 2019 (T+90)
21,000 shares@ US$1.1719.3% of flowCommon StockSEC:0001192482-18-000474:1
Canonical exit: 5 Feb 2019 (T+90)
25 of 46 declarations
About Aevi Genomic Medicine, LLC
Aevi Genomic Medicine, LLC is a company focused on developing genomic-based treatments for genetic diseases. It emphasizes innovation in the field of personalized medicine.
